These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19391220)

  • 1. Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization.
    Guillaudeau A; Durand K; Pommepuy I; Robert S; Chaunavel A; Lacorre S; DeArmas R; Bourtoumieux S; El Demery M; Moreau JJ; Labrousse F
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):220-6. PubMed ID: 19391220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy.
    Marquez A; Wu R; Zhao J; Tao J; Shi Z
    Diagn Mol Pathol; 2004 Mar; 13(1):1-8. PubMed ID: 15163002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
    Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
    Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
    Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
    Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
    Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
    J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR expression stratifies oligodendroglioma behavior.
    Horbinski C; Hobbs J; Cieply K; Dacic S; Hamilton RL
    Am J Pathol; 2011 Oct; 179(4):1638-44. PubMed ID: 21839716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of neu/c-erbB-2 in human brain tumors.
    Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
    Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin].
    Molnár P; Méhes G
    Magy Onkol; 2009 Mar; 53(1):33-8. PubMed ID: 19318324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
    Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
    J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M; Pollack IF; Hamilton RL; James CD
    Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain.
    Guillaudeau A; Durand K; Rabinovitch-Chable H; Pommepuy I; Mesturoux L; Robert S; Chaunavel A; Moreau JJ; Labrousse F
    Int J Oncol; 2012 Apr; 40(4):1142-52. PubMed ID: 22159595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma.
    Liao JB; Lee HP; Fu HT; Lee HS
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):374-382. PubMed ID: 27753660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.
    Burel-Vandenbos F; Turchi L; Benchetrit M; Fontas E; Pedeutour Z; Rigau V; Almairac F; Ambrosetti D; Michiels JF; Virolle T
    Neuro Oncol; 2013 Oct; 15(10):1278-88. PubMed ID: 23935154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas.
    Tabori U; Rienstein S; Dromi Y; Leider-Trejo L; Constantini S; Burstein Y; Dvir R; Amariglio N; Toren A; Rechavi G; Izraeli S; Aviram A
    J Neurosurg; 2005 Oct; 103(4 Suppl):357-61. PubMed ID: 16270688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
    Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
    J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior fossa recurrence of WHO grade II and III supratentorial gliomas.
    Terziev R; Petrirena G; Marie Y; Mueller WC; Bielle F; Delattre JY
    Rev Neurol (Paris); 2018 Dec; 174(10):705-710. PubMed ID: 30314742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.